Latest News - Page 7

Viral Hepatitis and Liver Cancer Development
BY DAVY JAMES, MANAGING EDITOR
Researchers seek a better understanding of the mechanism behind hepatocellular carcinoma.
HCV Antiviral Resistance a Challenge
BY GALE SCOTT
Genotypic resistance testing may help guide direct acting antiviral regimens.
Liver Transplant: Ribavirin Not Necessary to Prevent HCV Recurrence
BY GALE SCOTT
New antiviral drugs show promising results in liver transplant patients with recurrent HCV infection.
Researchers Accelerate Hepatitis C Vaccine Search
BY DAVY JAMES, MANAGING EDITOR
An HCV vaccine, while elusive, offers the best hope to eradicate the virus.
Liver Transplant Lists Grow Shorter
BY GALE SCOTT
The proportion of people on wait lists for livers who have HCV without liver cancer declines.
What Causes Natural Suppression of Hepatitis C Virus?
BY DAVY JAMES, MANAGING EDITOR
Researchers determine how the liver is able to naturally inhibit HCV infection.
Drug Trial Brings China Closer to Getting Access to HCV Antivirals
BY GALE SCOTT
There are currently an estimated 10 million people with HCV infections in China.
PCORI Awards $14 Million Grant for Study of Hepatitis C Among Drug Users
BY BILL SCHU
Injection drug users have a high rate of infection and some unique concerns in seeking HCV treatment.
$auto_registration$